|
|
供應(yīng) Lapatinib /231277-92-2 |
規(guī) 格: |
純度:99% |
價(jià) 格: |
550元/10mg/ |
數(shù) 量: |
10mg |
交貨地: |
|
發(fā)布時(shí)間: |
2016-12-02 |
有效期: |
3天 |
備 注: |
Introduction: Lapatinib, used in the form of lapatinib ditosylate, is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2).
CAS Number: 231277-92-2
Name: Lapatinib
Formula: C29H26ClFN4O4S
Molecular Weight: 581.06
Synonyms: GW572016;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;Lapatinib base;Lapatinib & its intermediates;Lapatinib(TINIBS);GW 572016;GSK 572016;Lapatinib [INN];
Density: 1.381 g/cm3
Boiling Point: 750.7 °C at 760 mmHg
Flash Point: 407.8 °C
|
結(jié)構(gòu)式: |
|
|
|